Patent ID: 9566399
Date: 2017-02-14
CPC Classifications: A61M

Claim:
1. A method of inhaling a nebulized vasoactive intestinal peptide for treating a disease, the method comprising the steps of: a. providing a vasoactive intestinal peptide dissolved in a diluent suitable for an aerosol inhalation device in the aerosol inhalation device, the device comprising: wherein the nebulizer generates aerosolized vasoactive intestinal peptide; b. introducing a pressurized gas into the pressurized gas inlet, generating an aerosol of the vasoactive intestinal peptide, the aerosolized vasoactive intestinal peptide traveling from the nebulizer to the inhalation chamber; c. inhaling a portion of the aerosolized vasoactive intestinal peptide through the inhalation mouthpiece assembly and simultaneously trapping a remaining portion of the aerosolized vasoactive intestinal peptide not being inhaled in the filter medium; and d. exhaling through the inhalation mouthpiece assembly, such that exhaled air travels through the inhalation chamber and the filter medium to the exit port for discharge to the atmosphere, wherein about 90% the aerosolized vasoactive intestinal peptide has a droplet size of about 1.4 microns or less and wherein the obscuration value of the aerosolized vasoactive intestinal peptide is between about 36.7 and about 42.